AI Article Synopsis

  • Interstitial cystitis/painful bladder syndrome is a debilitating condition diagnosed primarily through symptoms like pain and urgency, without a definitive diagnostic test currently available.* -
  • In a rat study, researchers used contrast-enhanced magnetic resonance imaging (MRI) with a special contrast agent to visualize bladder and colon effects after inducing interstitial cystitis with protamine sulfate.* -
  • The results showed significant changes in bladder permeability and colon uptake of the contrast agent, suggesting this MRI technique could be a promising diagnostic tool for interstitial cystitis and help understand the interactions between different organs.*

Article Abstract

Purpose: Interstitial cystitis/painful bladder syndrome is a devastating disease associated with multiple symptoms. It is usually diagnosed based on pain, urgency and frequency in the absence of other known causes. To our knowledge there is no diagnostic test to date.

Materials And Methods: In a model of rats intravesically exposed to protamine sulfate we performed in vivo diagnostic contrast enhanced magnetic resonance imaging with intravesical administration of Gd-diethylenetriamine pentaacetic acid contrast medium via a catheter to visualize increased bladder urothelium permeability. Gd-diethylenetriamine pentaacetic acid was administered intravenously to visualize secondary tissue effects in the colon.

Results: Bladder urothelium and colon mucosa were assessed 24 hours after bladder protamine sulfate exposure. Enhanced contrast magnetic resonance imaging established bladder urothelium leakage of Gd-diethylenetriamine pentaacetic acid according to the change in magnetic resonance imaging signal intensity in rats exposed to protamine sulfate vs controls (mean ± SD 399.7% ± 68.7% vs 39.2% ± 12.2%, p < 0.0001) as well as colon related uptake of contrast agent (mean 65.2% ± 17.1% vs 20.8% ± 9.8%, p < 0.01) after bladder protamine sulfate exposure. The kinetics of Gd-diethylenetriamine pentaacetic acid uptake and excretion were also assessed during 20 minutes of bladder and 30 minutes of colon exposure with increased signal intensity at 7 and 12 minutes, respectively.

Conclusions: These preliminary studies indicate that contrast enhanced magnetic resonance imaging can be used to monitor primary bladder urothelium loss of permeability and secondary enhanced contrast medium in the colon mucosa. It can be considered a potential clinical diagnostic method for interstitial cystitis/painful bladder syndrome that involves loss of the permeability barrier. It can also be used to assess visceral organ cross talk.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4706081PMC
http://dx.doi.org/10.1016/j.juro.2014.10.120DOI Listing

Publication Analysis

Top Keywords

magnetic resonance
20
resonance imaging
20
protamine sulfate
16
gd-diethylenetriamine pentaacetic
16
pentaacetic acid
16
bladder urothelium
16
contrast enhanced
12
enhanced magnetic
12
bladder
10
cross talk
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!